These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2769785)

  • 21. Evaluation of the combined effect of NIR laser and ionizing radiation on cellular damages induced by IUdR-loaded PLGA-coated Nano-graphene oxide.
    Kargar S; Khoei S; Khoee S; Shirvalilou S; Mahdavi SR
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():91-97. PubMed ID: 29155336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
    Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A
    Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraarterial iododeoxyuridine infusion combined with irradiation. A pilot study.
    Wirtanen GW; Wiley AL; Vermund H; Stephenson JA; Ansfield FJ
    Am J Clin Oncol; 1990 Aug; 13(4):320-3. PubMed ID: 2378311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hematoporphyrin derivative photoradiation therapy on survival in the rat 9L gliosarcoma brain-tumor model.
    Boggan JE; Bolger C; Edwards MS
    J Neurosurg; 1985 Dec; 63(6):917-21. PubMed ID: 2932542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor.
    Kassis AI; Tumeh SS; Wen PY; Baranowska-Kortylewicz J; Van den Abbeele AD; Zimmerman RE; Carvalho PA; Garada BM; DeSisto WC; Bailey NO; Castronovo FP; Mariani G; Black PM; Adelstein SJ
    J Nucl Med; 1996 Apr; 37(4 Suppl):19S-22S. PubMed ID: 8676198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft model.
    Harrington KJ; Syrigos KN; Uster PS; Zetter A; Lewanski CR; Gullick WJ; Vile RG; Stewart JS
    Br J Cancer; 2004 Jul; 91(2):366-73. PubMed ID: 15199395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model.
    Mairs RJ; Wideman CL; Angerson WJ; Whateley TL; Reza MS; Reeves JR; Robertson LM; Neshasteh-Riz A; Rampling R; Owens J; Allan D; Graham DI
    Br J Cancer; 2000 Jan; 82(1):74-80. PubMed ID: 10638969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation.
    Kinsella T; Safran H; Wiersma S; DiPetrillo T; Schumacher A; Rosati K; Vatkevich J; Anderson LW; Hill KD; Kunos C; Collins JM
    Clin Cancer Res; 2019 Oct; 25(20):6035-6043. PubMed ID: 31337643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IPdR: a novel oral radiosensitizer.
    Saif MW; Berk G; Cheng YC; Kinsella TJ
    Expert Opin Investig Drugs; 2007 Sep; 16(9):1415-24. PubMed ID: 17714027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regression.
    Wallenfriedman MA; Conrad JA; DelaBarre L; Graupman PC; Lee G; Garwood M; Gregerson DS; Jean WC; Hall WA; Low WC
    J Neurosurg; 1999 Jun; 90(6):1064-71. PubMed ID: 10350253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
    Macapinlac HA; Kemeny N; Daghighian F; Finn R; Zhang J; Humm J; Squire O; Larson SM
    J Nucl Med; 1996 Apr; 37(4 Suppl):25S-29S. PubMed ID: 8676200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent.
    Matalka KZ; Barth RF; Staubus AE; Moeschberger ML; Coderre JA
    Radiat Res; 1994 Jan; 137(1):44-51. PubMed ID: 8265787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of the efficacy of x-irradiation by pentobarbital in a rodent brain-tumor model.
    Olson JJ; Friedman R; Orr K; Delaney T; Oldfield EH
    J Neurosurg; 1990 May; 72(5):745-8. PubMed ID: 2324799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor uptake and mitotic activity pattern of 5-[125I]iodo-2'- deoxyuridine after intravesical infusion in patients with bladder cancer.
    Mariani G; Collecchi P; Baldassarri S; Di Luca L; Buralli S; Fontanini G; Baranowska-Kortylewicz J; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Apr; 37(4 Suppl):16S-19S. PubMed ID: 8676197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy of 5-methoxymethyl-2'-deoxyuridine, 9 beta-D-arabinofuranosyladenine and 5-iodo-2'-deoxyuridine in the treatment of experimental herpes simplex keratitis.
    Meldrum JB; Gupta VS; Babiuk LA
    Chemotherapy; 1980; 26(1):54-63. PubMed ID: 7353440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma.
    Bow H; Hwang LS; Schildhaus N; Xing J; Murray L; Salditch Q; Ye X; Zhang Y; Weingart J; Brem H; Tyler B
    J Neurosurg; 2014 Mar; 120(3):662-9. PubMed ID: 24359008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical animal studies with radioiododeoxyuridine.
    Kassis AI; Adelstein SJ
    J Nucl Med; 1996 Apr; 37(4 Suppl):10S-12S. PubMed ID: 8676195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas.
    Roelcke U; Hausmann O; Merlo A; Missimer J; Maguire RP; Freitag P; Radü EW; Weinreich R; Gratzl O; Leenders KL
    J Nucl Med; 2002 Nov; 43(11):1444-51. PubMed ID: 12411546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine.
    Manome Y; Kunieda T; Wen PY; Koga T; Kufe DW; Ohno T
    Hum Gene Ther; 1998 Jul; 9(10):1409-17. PubMed ID: 9681412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer.
    Van den Abbeele AD; Tutrone RF; Berman RM; Baranowska-Kortylewicz J; Barclay PD; Richie JP; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Feb; 37(2):315-20. PubMed ID: 8667069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.